فاس نيوز ميديا جريدة الكترونية جهوية تعنى بشؤون و أخبار جهة فاس مكناس – متجددة على مدار الساعة
Source: Moroccan Network for the Defense of the Right to Health and the Right to Life
A recent report by the Moroccan Network for the Defense of the Right to Health and the Right to Life revealed a concerning surge in drug prices in Morocco, with increases reaching 3-5 times compared to other countries.
The report confirmed that the Moroccan government, through the Minister Delegate in charge of the Budget, Fouzi Lekjaa, officially acknowledged this phenomenon. Lekjaa pointed out that some drugs previously imported for 10 dirhams a decade ago are now sold for 70 or 80 dirhams.
Dr. Lhlo Filali revealed that all drugs in Morocco (except generic drugs) are imported, despite national actors’ ability to produce up to 50% of them.
The report highlighted that drug prices in Morocco exceed those in Belgium and France by 3-4 times, and in some cases can reach 250-1000% higher.
The pharmaceutical sector comprises 54 laboratories, with 15 laboratories controlling 70% of market shares, featuring concentrated monopolies and a lack of transparency.
The Moroccan Network for the Defense of the Right to Health called for:
- Reviewing drug pricing decrees
- Achieving health and pharmaceutical sovereignty
- Reforming the legal drug system
- Encouraging national production
- Monitoring drug prices
The report concluded by emphasizing that the right to life is directly linked to accessing healthcare services and affordable medications.
